Let-7 miRNA profiles are associated with the reversal of left ventricular hypertrophy and hypertension in adult male offspring from mothers undernourished during pregnancy after preweaning growth hormone treatment

Endocrinology

Volumn 155, Issue 12, 2014, Pages 4808-4817

  Gray, Clint ^a   Li, Minglan ^a   Patel, Rachna ^a   Reynolds, Clare M ^a   Vickers, Mark H ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; MICRORNA; MIRNLET7 MICRORNA, RAT;

ANIMAL; BIRTH WEIGHT; BLOOD PRESSURE; DRUG EFFECTS; DRUG SCREENING; EMBRYOLOGY; FEMALE; FETAL MALNUTRITION; HEART; HEART MUSCLE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MALNUTRITION; MATERNAL NUTRITION; METABOLISM; PREGNANCY; PRENATAL EXPOSURE; SPRAGUE DAWLEY RAT;

ANIMALS; BIRTH WEIGHT; BLOOD PRESSURE; DRUG EVALUATION, PRECLINICAL; FEMALE; FETAL NUTRITION DISORDERS; GROWTH HORMONE; HEART; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MALNUTRITION; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MICRORNAS; MYOCARDIUM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS, SPRAGUE-DAWLEY;

EID: 84914126594     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1567     Document Type: Article

References (56)

1. Harvey RP. Patterning the vertebrate heart. Nat Rev Genet. 2002;3(7):544-556.
2. Barker DJP, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986;327(8489):1077-1081.
3. Barker DJP, Fall C, Osmond C, et al. Weight in infancy and death from ischaemic heart disease. Lancet. 1989;334(8663):577-580.
4. Roseboom TJ, van der Meulen JH, et al. Blood pressure in adults after prenatal exposure to famine. J Hypertens. 1999;17:325-330.
5. Schulz LC. The Dutch Hunger Winter and the developmental origins of health and disease. Proc Natl Acad Sci USA. 2010;107(39):16757-16758.
6. Roseboom T, de Rooij S, Painter R. The Dutch famine and its longterm consequences for adult health. Early Hum Dev. 2006;82:485-491.
7. Kwong WY, Wild AE, Roberts P, Willis AC, Fleming TP. Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development. 2000;127(19):4195-4202.
8. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 2007;8(2):93-103.
9. Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 2013;14(8):475-488.
10. Thum T, Galuppo P, Wolf C, et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation. 2007;116(3):258-267.
11. Bruneau BG. Developmental biology: tiny brakes for a growing heart. Nature. 2005;436(7048):181-182.
12. Tatsuguchi M, Seok HY, Callis TE, et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol. 2007;42(6):1137-1141.
13. Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation. 2010;121(8):1022-1032.
14. Vonnahme KA, Hess BW, Hansen TR, et al. Maternal undernutrition from early- to mid-gestation leads to growth retardation, cardiac ventricular hypertrophy, and increased liver weight in the fetal sheep. Biol Reprod. 2003;69(1):133-140.
15. Gaedickea S, Zhangb X, Schmelzera C, et al. Vitamin E dependent microRNA regulation in rat liver. FEBS Lett. 2008;582(23-24):3542-3546.
16. Mohri T, Nakajima M, Takagi S, Komagata S, Yokoi T. MicroRNA regulates human vitamin D receptor. Int J Cancer. 2009;125(6):1328-1333.
17. Marsit CJ, Eddy K, Kelsey KT. MicroRNA responses to cellular stress. Cancer Res. 2006;66(22):10843-10848.
18. Maloyan A, Muralimanoharan S, Huffman S, et al. Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity. Physiol Genomics. 2013;45(19):889-900.
19. Woodall SM, Breier BH, Johnston BM, Gluckman PD. A model of intrauterine growth retardation caused by chronic maternal undernutrition in the rat: effects on the somatotrophic axis and postnatal growth. J Endocrinol. 1996;150:231-242.
20. Woodall SM, Bassett NS, Gluckman PD, Breier BH. Consequences of maternal undernutrition for fetal and postnatal hepatic insulinlike growth factor-I, growth hormone receptor and growth hormone binding protein gene regulation in the rat. J Mol Endocrinol. 1998;20:313-326.
21. Smith T, Sloboda DM, Saffery R, Joo E, Vickers MH. Maternal nutritional history modulates the hepatic IGF-IGFBP axis in adult male rat offspring. Endocrine. 2014;46(1):70-82.
22. El Khattabi I, Remacle C, Reusens B. The regulation of IGFs and IGFBPs by prolactin in primary culture of fetal rat hepatocytes is influenced by maternal malnutrition. Am J Physiol Endocrinol Metab. 2006;291(4):E835-E842.
23. Randhawa RS. The insulin-like growth factor system and fetal growth restrictionn. Pediatr Endocrinol Rev. 2008;6:235-240.
24. Hwa V, Fang P, Derr MA, Fiegerlova E, Rosenfeld RG. IGF-I in human growth: lessons from defects in the GH-IGF-I axis. Nestle Nutr Inst Workshop Ser. 2013;71:43-55.
25. Gray C, Li M, Reynolds CM, Vickers MH. Pre-weaning growth hormone treatment reverses hypertension and endothelial dysfunction in adult male offspring of mothers undernourished during pregnancy. PLoS One. 2013;8(1):e53505.
26. Reynolds CM, Li M, Gray C, Vickers MH. Preweaning growth hormone treatment ameliorates adipose tissue insulin resistance and inflammation in adult male offspring following maternal undernutrition. Endocrinology. 2013;154(8):2676-2686.
27. Reynolds CM, Li M, Gray C, Vickers MH. Pre-weaning growth hormone treatment ameliorates bone marrow macrophage inflammation in adult male rat offspring following maternal undernutrition. PLoS One. 2013;8(7):e68262.
28. Williams SJ, Campbell ME, McMillen IC, Davidge ST. Differential effects of maternal hypoxia or nutrient restriction on carotid and femoral vascular function in neonatal rats. Am J Physiol Regul Integr Comp Physiol. 2005;288:R360-R367.
29. Han HC, Austin KJ, Nathanielsz PW, Ford SP, Nijland MJ, Hansen TR. Maternal nutrient restriction alters gene expression in the ovine fetal heart. J Physiol. 2004;558:111-121.
30. Vickers KC, Rye KA, Tabet F. MicroRNAs in the onset and development of cardiovascular disease. Clin Sci (Lond). 2014;126(3): 183-194.
31. Nishi H, Ono K, Iwanaga Y, et al. MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J Biol Chem. 2010;285(7):4920-4930.
32. Yang T, Zhang GF, Chen XF, et al. MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2. Biochem Biophys Res Commun. 2013;436(4):578-584.
33. Wang C, Wang S, Zhao P, et al. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression. J Cell Biochem. 2012;113(6):2040-2046.
34. Rangrez AY, Kumari M, Frey N. An emerging role of microRNA miR-223 in cardiovascular pathophysiology. microRNA Cardiovasc Res. 2013;1:23-33.
35. WangK, Lin ZQ, Long B, Li JH, Zhou J, Li PF. Cardiac hypertrophy is positively regulated by microRNAmiR-23a. J Biol Chem. 2012;287(1):589-599.
36. Han M, Yang Z, Sayed D, et al. GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy. Cardiovasc Res. 2012;93(4):645-654.
37. Sucharov C, Bristow MR, Port JD. miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol. 2008;45(2): 185-192.
38. Duan J, Huang H, Lv X, et al. PKHD1 post-transcriptionally modulated by miR-365-1 inhibits cell-cell adhesion. Cell Biochem Funct. 2012;30(5):382-389.
39. Kim HW, Mallick F, Durrani S, Ashraf M, Jiang S, Haider KH. Concomitant activation of miR-107/PDCD10 and hypoxamir-210/Casp8ap2 and their role in cytoprotection during ischemic preconditioning of stem cells. Antioxid Redox Signal. 2012;17(8):1053-1065.
40. Liu LF, Liang Z, Lv ZR, et al. MicroRNA-15a/b are up-regulated in response to myocardial ischemia/reperfusion injury. J Geriatr Cardiol. 2012;9:28-32.
41. Aurora AB, Mahmoud AI, Luo X, et al. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death. J Clin Invest. 2012;122(4):1222-1232.
42. Porrello ER, Johnson BA, Aurora AB, et al. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ Res. 2011;109(6):670-679.
43. Botting KJ, Wang KC, Padhee M, et al. Early origins of heart disease: low birth weight and determinants of cardiomyocyte endowment. Clin Exp Pharmacol Physiol. 2012;39:814-823.
44. Rougvie AE. Control of developmental timing in animals. Nat Rev Genet. 2001;2(9):690-701.
45. Ambros V. microRNAs: tiny regulators with great potential. Cell. 2001;107(7):823-826.
46. Tan KS, Armugam A, Sepramaniam S, et al. Expression profile of MicroRNAs in young stroke patients. PLoS One. 2009;4(11):e7689.
47. Yuan Y, Wang JY, Xu LY, Cai R, Chen Z, Luo BY. MicroRNA expression changes in the hippocampi of rats subjected to global ischemia. J Clin Neurosci. 2010;17(6):774-778.
48. Yang Y, Ago T, Zhai P, Abdellatif M, Sadoshima J. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circ Res. 2011;108(3):305-13.
49. Gantier MP, Stunden HJ, McCoy CE, et al. A miR-19 regulon that controls NF-κB signaling. Nucleic Acids Res. 2012;40(16):8048-8058.
50. Zhang X, Yu H, Lou JR, et al. MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. J Biol Chem. 2011;286:1429-1435.
51. Lijnen PJ1, Petrov VV, Fagard RH. Induction of cardiac fibrosis by transforming growth factor-β. Mol Genet Metab. 2000;71(1-2):418-435.
52. Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol. 2011;51(4):600-606.
53. Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS. Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation. 2008;118:863-871.
54. Kanashiro-Takeuchi RM, Tziomalos K, Takeuchi LM, et al. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc Natl Acad Sci USA. 2010;107: 2604-2609.
55. Brüel A, Oxlund H, Nyengaard JR. Growth hormone increases the total number of cardiac myocyte nuclei in young rats but not in old rats. Mech Ageing Dev. 2002;123:1353-1362.
56. Brüel A, Christoffersen TE, Nyengaard JR. Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart. Cardiovasc Res. 2007;76:400-408.